Neuroendocrinological signs of central neurotransmission disorders.
Modulation mechanisms of nociception have several neurotransmission interactions that are impaired in the disorder of painful perceptions. Neurotransmission changes may show up in several ways on the clinical level. They also have endocrinological correlations, since the neurotransmission systems implicated in the nociception disorders share transmitters with the regulation system operating at the pituitary level. In this sense, nocipathies exhibit analogies and may be compared to disorders of motricity and behaviour that also show endocrine changes that may be likewise explained. Though specifically different in each instance, the neurotransmission alteration that is a common denominator of these disorders allows comparisons, especially in those situations, such as the nocipathic and behavioural ones, where correlations are relevant on clinical and interpretative grounds.
D000375:Aging; D002493:Central Nervous System Diseases / Q000503:physiopathology*; D004700:Endocrine System Diseases / Q000503:physiopathology*; D006261:Headache / Q000503:physiopathology; D006801:Humans; D007980:Levodopa / Q000494:pharmacology; D018377:Neurotransmitter Agents / Q000378:metabolism; D009619:Nociceptors / Q000187:drug effects*; D009627:Nomifensine / Q000494:pharmacology; D010507:Periodicity; D011388:Prolactin / Q000097:blood
D018377:Neurotransmitter Agents; D009627:Nomifensine; D007980:Levodopa; D011388:Prolactin